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Accuracy 84.9% (73.0%–92.1%)
Sensitivity 76.5% (52.7–90.4%)
Speciﬁcity 88.9% (74.7–95.6)
Execution Time 35.2  8.4 sec.
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angiography has a high diagnostic accuracy and correlates closely
with invasively determined iFR. Future research activities will focus
on model reﬁnement and further validation of the method.
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BACKGROUND Patients with aortic valve stenosis (AS) have a
reduced coronary ﬂow reserve (CFR) despite angiographically normal
coronary arteries. Previous researches have employed non-invasive
techniques to determine the CFR. The aim of the study is to invasive
assess the CFR and identify which variables are related to it. Sec-
ondary objective: Investigate the tolerability of adenosine infusion in
AS patients.
METHODS 35 patients with severe AS, who were referred for cardiac
catheterization were enrolled in this prospective study. Patients with
severe aortic regurgitation or mitral valve disease were excluded.
Patients with fractional ﬂow reserve (FFR) in left anterior descending
(LAD) < 0.75 or severe angiographic stenosis were excluded. A pres-
sure sensor/thermistor-tipped guidewire was used and CFR was
calculated from the ratio of the mean transit times in hyperemia and
at rest. CFR and other physiological measurements were performed in
the LAD. Maximal hyperemia was induced by adenosine perfusion
(140mcg/kg/min).
RESULTS CFR was measured in 33 patients (two patients were
excluded for FFR<0.75 and for a technical problem). 57% of the pa-
tients were males with a mean age of 71+/-8 years. All procedures
were performed by radial approach. CFR showed a median value of
1.39+/-0.57 and was concordant with a coronary microvascular
dysfunction and statistically associated with IMR (r¼ -04 p 0.03). A
signiﬁcant association between CFR and BNP levels were found
(r¼ -0.38, p 0,02). A nonsigniﬁcant correlation with left ventricle in-
dex mass and CFR was found ( r¼ 0.38, p 0,08). No signiﬁcant rela-
tionship between CFR and other clinical, biochemical, physiological
or echocardiogram parameters were found. Patients with CFR> 2 had
lower indexed ventricular mass (113  27 vs 146  34 g / m2, p ¼ 0.08),
increased aortic valve area (AVA) (0.72  0.18 vs 0.63  0.05, p ¼
0.04) and lower NT-proBNP (541  543 vs. 2075  3746, p ¼ 0.05).
Regarding adenosine infusion: Heat sensation of the face, chest
discomfort and dyspnea were the most frequent complaints of the
subjects during the infusion. 82% of the subject experienced at least
one of these symptoms, although these symptoms were transient and
disappeared immediately after termination of the infusion. There
were no severe side effects and all the patients completed the
protocol.Characteristics Percentage / ValueDiabetes 24%Hypertension 55%Smoker 18%Heart rate (Basal) 77 +/-19 bpmMean transit time (Hyperemia) 0.42+/- 0.19 sec.Mean transit time (Basal) 0.53+/-22 sec.FFR 0.88 +/- 0.06IMR 32+/-16Index AVA 0.45 +/-0.11 cm2/m2CONCLUSIONS Invasive CFR measurement conﬁrm, that patients
with AS and normal coronary arteries have a coronary microvascular
dysfunction. CFR showed a median value of 1,39+/-0,57 and was sta-
tistically associated with IMR, BNP levels and AVA. Adenosine
perfusion is a safe and relatively well-tolerated in AS patient.
CATEGORIES IMAGING: FFR and Physiologic Lesion Assessment
KEYWORDS Aortic stenosis, Coronary ﬂow reserve, Coronary micro-
circulation
TCT-42
Accounting for right atrial pressure in the calculation of Fractional Flow
Reserve (FFR) signiﬁcantly increases the number of physiologically
signiﬁcant stenoses suitable for PCI
Christopher Cook,1 Yousif Ahmad,2 Ricardo Petraco,3
Sukhjinder S. Nijjer,1 Rasha Al-Lamee,4 Mauro Echavarria-Pinto,5
Jason M. Tarkin,3 Carlo Di Mario,2 Iqbal S. Malik,6 Javier Escaned,7
Sayan Sen,2 Justin E. Davies2
1Imperial College London, London, London; 2Imperial College London,
London, United Kingdom; 3Imperial College, London, United Kingdom;
4IMPERIAL COLLEGE NHS TRUST, London, London; 5Hospital
Universitario Clinico San Carlos, Madrid, Spain; 6Imperial College NHS
Trust, London, London; 7Hospital Clinico San Carlos, Madrid, Spain
BACKGROUND Ameasure of right atrial pressure (RAP)was included in
the original FFR calculation [FFRmyo¼ Pd – RAP / Pa - RAP], but is now
omitted from FFR in contemporary clinical use [FFRmyo¼ Pd / Pa]. We
investigated the effect omission of RAP from the calculation of FFR has
on revascularization decisions made in everyday clinical practice.
METHODS 304 coronary stenoses underwent coronary angiography
with FFR measurement. FFR was calculated using both the simpliﬁed
equation of distal coronary pressure/proximal aortic pressure (Pd/Pa),
and also accounting for right atrial pressure (Pd–RAP/Pa-RAP) across a
range of right atrial pressure values between 0-15 mmHg. The impli-
cations on revascularization decision making were assessed.
RESULTS Mean FFR (Pd/Pa) of the cohort was 0.83 (0.09). The in-
clusion of RAP signiﬁcantly decreased the FFR value. Mean FFR of the
cohort decreased to 0.82 (0.10), 0.81 (0.11) and0.79 (0.11) at RAPs of
5mmHg, 10mmHg and 15mmHg respectively. The decrease reached
statistical signiﬁcance at RAP 7 mmHg (p<0.04), within the published
normal RAP range (<8mmHg). Decrease in FFR increased the propor-
tion of stenoses meeting revascularization criteria (FFR0.80). Due to
the clustering of data around FFR 0.80, small changes in FFR value led
to big changes in classiﬁcation. The additional stenoses fulﬁlling
reclassiﬁcation criteria were 4% (11/304), 9% (27/304) and 17% (51/304)
at RAPs of 5mmHg, 10mmHg and 15mmHg respectively. These repre-
sented potentially missed cases for appropriate revascularization. In
this cohort, FFR 0.83 was the highest non-signiﬁcant FFR that reclas-
siﬁcation still occurred at normal RAP (<8mmHg). In patients with
elevatedRAP (15mmHg), this Figurewas FFR0.85. These FFRvalues are
well above the FFR0.80 cut off for revascularization. Lastly, when
RAP was included, systolic aortic blood pressure (Pa) became an
important determinant of the FFR value. RAP always lowered the FFR
of a stenosis more in patients with low systolic blood pressure.
Therefore, the inclusion of RAP is non-linear, and its effects on FFR
calculation are critically dependent on the systolic aortic pressure.
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derestimates true stenosis severity, oversimpliﬁes the relationship
with systolic aortic pressure and potentially denies patients the
opportunity for appropriate revascularization.
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Abstract nos: 43 - 50Table. 8-mo follow-up OCT ﬁndings
Variables
Late phase SM
(22)
No Late phase SM
(63) P
Average NIT (mm) 60.6626.86 90.8236.03 0.001
% Uncovered strut
(%)
2.453.13 0.591.38 <0.001
IS-Th (%) 5 (22.7) 1 (1.6) 0.004
Variables
LASM
(17)
No LASM
(68) P
Average NIT (mm) 63.2029.63 88.036.26 0.011
% Uncovered strut
(%)
2.583.47 0.691.45 0.001
IS-Th (%) 4 (23.5) 2 (2.9) 0.013
NIT: Neoointimal thicknessTCT-43
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BACKGROUND Drug eluting stent (DES) thrombosis may be triggered
by different phenomenon that require speciﬁc treatment and can vary
according to the device properties. However, angiography alone is
frequently limited to correctly identify these mechanisms. The pre-
sent work aimed to investigate and compare the characteristics and
mechanisms of stent thrombosis (ST) between 1st (paclitaxel -and
sirolimus-eluting stents) and 2nd generation (everolimus- and zotar-
alimus eluting stents) among a large cohort of patients explored by
optical coherence tomography (OCT).
METHODS The PESTO study was a prospective national registry
involving 29 French catheterization labs. Patients with acute coronary
syndromes (ACS) were prospectively screened for presence of deﬁnite
ST and explored by OCT after culprit lesion deocclusion. ST was
classiﬁed as acute (AST), sub-acute (SAST), late (LST) and very late
(VLST). Baseline clinical, biological and angiographic characteristics
were collected for each subject. Three independent operators un-
aware of patients’ characteristics reviewed OCT data to identify the ST
etiologies.
RESULTS The ﬁnal analysis involved n¼69 subjects (age 62.01.5 y,
90% male), including n¼34 patients with 1st generation DES (DES1g)
and n¼35 patients with 2nd generation DES (DES2g). VLST was the
clinical presentation in 80 %, LST in 3 % and SAST+AST in 17 % of
the patients. The delay between initial PCI and ST was longer
(4.80.6 vs. 1.60.3 y, p<0.0001) and there were fewer patients
under double anti-platelet therapy (5.9% vs. 40%, p¼0.001) in the
DES1g vs. DES2g groups. OCT identiﬁed an underlying morpholog-
ical abnormality in 95.7% of the cases, including struts signiﬁcant
malapposition (33.3%), ruptured neoatherosclerotic lesion (14.5%),
stent major underexpansion (13%), coronary evaginations (13%),
isolated struts uncoverage (11.6%), neointimal hyperplasia with
thrombus (4.3%) and edge related disease progression (4.3%).
Ruptured neoatherosclerotic lesions were more frequently observed
in DES1g than in DES2g (26.5 vs. 2.9%, p<0.01) but there was no
signiﬁcant difference between groups regarding the other abnor-
malities (including coronary evaginations). Furthermore, there was
no signiﬁcant difference regarding the percentage of malapposed
struts (7.9 vs. 7.1%) and uncovered struts (29.2 vs. 35.8 %) between
groups.
CONCLUSIONS In this prospective registry, DES thrombosis
mainly occurred  1 year after initial procedure and involved 1stand 2nd generation DES. Ruptured neoatherosclerosis was more
frequent in DES1g than in DES2g group, but this observation
might be related to the longer delay between initial PCI and ST
in paclitaxel- or sirolimus-eluting stents patients compared to
the others.
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BACKGROUND Although the occurrence of stent-malapposition (SM)
after percutaneous coronary intervention (PCI) has been reduced
in accordance of progress of imaging device, late acquired stent-
malapposition (LASM) is still a well-recognized problem. Previous
studies suggested late phase SM can be a substrate for (very) late stent
thrombosis. However, the predictors are still unclear. We clariﬁed the
predictors of late phase SM, and evaluated the relation between late
phase SM and in-stent thrombus (IS-Th) by optical coherence to-
mography (OCT).
METHODS PRASFIT-Elective is a multicenter, parallel-group study
of PCI patients receiving either prasugrel or clopidogrel, in addition
to aspirin. 85 lesions in 73 patients were enrolled for serial OCT
sub-study. All lesions were performed pre-, post-PCI, and 8-mo
follow-up OCT analysis, and quantitative coronary angiography
analysis (QCA). Lipid index (averaged lipid arclipid length), ﬁbrous
cap thickness (FCT), and max arc of macrophage inﬁltration were
measured before PCI, and the total area of acute SM and IS-Th post
PCI were analyzed in association with late phase SM at 8-mo OCT.
Platelet reactivity, P2Y12 Reactive Unit (PRU) was measured at
8-mo.
RESULTS Acute SM was observed in 40 lesions (47.1%), and 13
lesions (32.5%) of them showed persistent SM and others were
resolved SM at 8-mo. Logistic regression analysis revealed the
total area of acute SM was an independent factor for persistent
SM (p¼0.037). LASM was observed in 17 lesions (20.0%). The size,
vulnerability, and inﬂammation of lipid plaque were independent
risk factors for LASM (Figure). In 8-mo OCT analysis, late phase
SM was associate with persistent IS-Th (p¼0.004) (Table). There
was no differences in PRU among resolved, persistent, and late
acquired SM (PRU:191.8082.18 vs. 141.25101.51 vs. 199.8182.96
p¼NS).
